Paul Reider

Chief Commercial Officer, Coherus BioSciences (United States).

Companies

Coherus BioSciences (United States)Chief Commercial Officer Mar 28, 2023 to now¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Coherus BioSciences (United States) CHRS82,069 shares²$81.2K at $0.99Jan 20, 2025

As of each latest filing. The line shows shares held over time.

Jan 20, 2025Shares withheld for tax 4,858 shares at $1.39 of Coherus BioSciences (United States)²
Jan 4, 2025Shares withheld for tax 2,277 shares at $1.66 of Coherus BioSciences (United States)³
Dec 13, 2024Shares withheld for tax 2,073 shares at $1.61 of Coherus BioSciences (United States)⁴
Jan 20, 2024Shares withheld for tax 4,854 shares at $2.44 of Coherus BioSciences (United States)⁵
Jan 4, 2024Shares withheld for tax 2,275 shares at $2.92 of Coherus BioSciences (United States)⁶
Dec 13, 2023Shares withheld for tax 2,049 shares at $2.37 of Coherus BioSciences (United States)⁷
Apr 1, 2023Shares withheld for tax 2,451 shares at $6.84 of Coherus BioSciences (United States)⁸

The numbers on this page point here. Each one links to the record it came from.